Accessibility Menu
Atlas Arteria logo

Atlas Arteria(ASX) ALX

Market CapA$7.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+1,632%
5 Year+15%
1 Year+3%
1 Month-2%
A$5.00
+0.20%
+0.01Today
Atlas Arteria last closing stock price
MetricPriceDate
Last closeAUD 5.002026-08-06
Atlas Arteria stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.99%AUD 5.052026-07-30
1 month-1.96%AUD 5.102026-07-07
3 month+4.6%AUD 4.782026-05-08
Year to date+7.2%AUD 4.662025-12-31
1 year+2.98%AUD 4.862025-08-06
3 year+3.57%AUD 4.832023-08-07
5 year+14.81%AUD 4.362021-08-06
Since inception+1,632.29%AUD 0.292010-01-25

Atlas Arteria Financials at a Glance

Market Cap

A$7.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$266.25M

Net Income (TTM)

A$481.20M

EPS (TTM)

A$0.16

P/E Ratio

32.15

Dividend

A$0.40

Beta (Volatility)

0.07 (Low)

Price

A$5.00

Volume

0

Open

A$4.96

Previous Close

A$5.00

Daily Range

A$4.96 - A$5.00

52-Week Range

A$4.20 - A$5.54

Estimated Earnings Date

Aug 27, 2026

ALX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atlas Arteria

Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. The company holds a significant equity stake in Toll Road Investors Partnership II, which operates the Dulles Greenway toll road in Virginia, USA. Established in 2009 and headquartered in Melbourne, Australia, Atlas Arteria has rebranded from Macquarie Atlas Roads Limited to its current name in May 2018.

Products and Services
  • Management of toll road assets
  • Investment in infrastructure projects
  • Partnerships with concessionaires for road operations
Growth Outlook
  • Recent quarterly revenue reached AUD 82.5 million, indicating strong operational performance
  • Trailing twelve months (TTM) net income of AUD 152.3 million reflects robust profitability
  • Dividend yield of 7.88% suggests attractive returns for investors
Financial Highlights
  • TTM revenue of AUD 305 million demonstrates consistent revenue generation
  • Net profit margin of 1.70% indicates effective cost management
  • Operating cash flow of AUD 282.5 million in the latest quarter supports financial stability
Atlas Arteria Limited is positioned in the industrial infrastructure sector, focusing on toll road operations. The company's strategic investments and management of toll road assets provide a solid foundation for growth. Recent financial performance highlights, including a significant quarterly revenue increase and a strong net income, underscore the company's operational efficiency. The attractive dividend yield further enhances its appeal to potential investors. With a focus on infrastructure development and management, Atlas Arteria is well-placed to capitalize on future growth opportunities in the transportation sector.
AI Generated • Jul 21, 2026

Industry

Transportation Infrastructure

CEO

Hugh Wehby

Headquarters

Melbourne, VIC 3000, AU

ALX Financials

Key Financial Metrics (TTM)

Gross Margin

23.75%

Operating Margin

9.44%

Net Income Margin

169.81%

Return on Equity

3.46%

Return on Capital

-0.10%

Return on Assets

2.68%

Earnings Yield

3.11%

Dividend Yield

8.00%

Payout Ratio

2.11%

Stock Overview

Market Cap

A$7.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.45B

Volume

0

Avg. Volume

9.61M

Financials (TTM)

Gross Profit

A$51.10M

Operating Income

A$4.25M

EBITDA

A$145.95M

Operating Cash Flow

A$1.02B

Capital Expenditure

-A$1.40M

Free Cash Flow

A$1.02B

Cash & ST Invst.

A$274.40M

Total Debt

A$1.75B

Atlas Arteria Performance Analysis

Atlas Arteria annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31AUD 118,241,00017.6%
20232023-12-31AUD 134,000,00013.3%
20242024-12-31AUD 145,900,0008.9%
20252025-12-31AUD 160,000,0009.7%
Atlas Arteria sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-1.3%
Q42024-12-318.3%
Q22025-06-30-48.6%
Q42025-12-31112.9%
Atlas Arteria annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31AUD 0.2239.4%
20232023-12-31AUD 0.18-20.5%
20242024-12-31AUD 0.2331.1%
20252025-12-31AUD 0.18-22.8%
Atlas Arteria sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-4.5%
Q42024-12-3139.8%
Q22025-06-30-66.4%
Q42025-12-31170.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$82.50M

+17.0%

Gross Profit

A$1.80M

-76.9%

Gross Margin

2.18%

N/A

Market Cap

A$7.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$145.35M

N/A

Employees

50

N/A

Net Income

A$152.30M

+27.1%

EBITDA

A$23.00M

-53.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$274.40M

-10.1%

Total Debt

A$1.75B

+1.6%

Accounts Receivable

A$11.20M

-64.3%

Inventory

A$0.00

N/A

Long Term Debt

A$1.64B

+1.4%

Short Term Debt

A$106.00M

+4.2%

Return on Assets

2.68%

N/A

Return on Invested Capital

0.15%

N/A

Free Cash Flow

A$282.50M

-33.8%

Operating Cash Flow

A$282.50M

-33.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AZJ.AXAurizon Holdings Limited
A$4.21-1.17%
SEK.AXSEEK Limited
A$15.37+1.99%
QUB.AXQube Holdings Limited
A$5.11-0.20%
CWY.AXCleanaway Waste Management Limited
A$2.39+0.42%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$114.92+0.06%
NVDANvidia
$218.99-0.00%
TTDThe Trade Desk
$17.67-0.07%
SOUNSoundHound AI
$7.08+0.10%

Questions About ALX

What is the current price of Atlas Arteria?

Atlas Arteria is trading at A$5.00 per share.

What is the 52-week range for Atlas Arteria?

Over the past 52 weeks, Atlas Arteria has traded between A$4.20 and A$5.54.

How much debt does Atlas Arteria have?

As of the most recent reporting period, Atlas Arteria reported total debt of A$1.72B.

How much cash does Atlas Arteria have on hand?

Atlas Arteria reported A$274.40M in cash and cash equivalents in its most recent financial results.

What is Atlas Arteria’s dividend yield?

Atlas Arteria currently has a dividend yield of 8.00%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.